What Nanjing Caichang Trading Co.，Ltd does

Tongfang Pharmaceutical (Beijing) Co., Ltd. (桐方药业（北京）有限公司) is a China-based integrated pharmaceutical manufacturer founded in 1993 as Beijing Badaling Pharmaceutical Factory. The company maintains a full-industry chain spanning R&D (centers in Beijing and Chongqing), production (a 269 mu / ~179,333 sqm GMP-certified campus in Zhongguancun Science Park Yanqing Park, Beijing), and B2B sales into healthcare institutions. Its pharmaceutical portfolio covers gynecological medications (Metronidazole Vaginal Gel, Huangtengsu Vaginal Gel, Anti-gongyan Dispersible Tablets), topical anesthetics (Compound Lidocaine Cream), anti-tumor drugs (Exemestane Tablets for breast cancer endocrine therapy), and hepatobiliary/anti-infective products (Meloxicam Tablets, Chuipencao Dispersible Tablets, Cephalosporin powder injections) — 17 drug varieties and 27 specifications across 8 GMP-certified production lines. A consumer health food line (probiotics, protein powders, Dongfang Xinyi gift boxes, botanical beverages) is sold through similar channels, positioned for family health management and gifting scenarios.

Commercially, the company sells through direct enterprise channels to hospitals, clinics, and pharmacies (with dedicated sales hotlines for product agency) and participates in national industry events such as the 92nd National Pharmaceutical Trade Fair. Compound Lidocaine Cream is distributed internationally via the Bill & Melinda Gates Foundation's African male circumcision public-health project, providing a rare global-health channel credential for a mid-sized Chinese generic manufacturer. The company is controlled by Shanxi Construction Investment Group and consolidated under Hong Kong-listed Huakang Kangtai Group (HK.01312), with 200 million RMB in registered capital and a workforce of 33 years' cumulative industry experience. Notable recognitions include National High-Tech Enterprise status, Beijing Specialized Refined and Innovative SME (2022), National Worker Pioneer award (2024), and Zhongguancun High-Tech Enterprise certification (2024). The company was renamed from 'Xingkong Zaixian Pingtai-Xingkong (China)' to 'Tongfang Pharmaceutical (Beijing) Co., Ltd.' in May 2026 to sharpen its pharmaceutical brand positioning.

Firmographics surfaced under the name Nanjing Caichang Trading Co., Ltd (founded 2011, 5 employees, caichon.com website) appear to represent a registered trading entity used alongside the broader Tongfang Pharmaceutical operating group. No revenue figure is disclosed for either entity.

Name

Nanjing Caichang Trading Co.，Ltd

Legal name

桐方药业（北京）有限公司

Website

https://caichon.com

Company type

Private

Founded year

1993

Operating status

Operating

Headcount range

1–10 employees

Short description

Tongfang Pharmaceutical (Beijing) Co., Ltd. operates an integrated pharmaceutical R&D, manufacturing, and B2B sales platform in China, producing generic gynecological, anti-tumor, hepatobiliary, anti-infective, and topical anesthetic drugs plus a consumer health-food line. Its products reach hospitals, pharmacies, and international public-health programs via direct enterprise sales and trade-fair channels.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health) (HLAIAAAJ)

akta.pro secondary industry

Better-for-You / Functional Snacks (Low Sugar, Keto, Probiotic, Fortified) (CRADABAM)

Keywords

• Pharmaceutical manufacturing
• Gynecological medications
• Topical anesthetics
• Health food products
• Anti-tumor drugs

Headquarters

HQ city

Beijing

HQ country

China

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: The company generates revenue through the sale of pharmaceutical products including gynecological medications, topical anesthetics, hepatobiliary medications, anti-infectives, and anti-tumor drugs to healthcare institutions and medical facilities through enterprise sales channels.
2. Health Food Product Sales: Revenue from health food products including probiotics, protein powders, and medicinal food homology nutritional supplements sold to consumers and through distribution channels.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

Nanjing Caichang Trading Co.，Ltd, associated with Tongfang Pharmaceutical (Beijing) Co., Ltd., manufactures and sells proprietary pharmaceutical products across gynecological, topical anesthetic, anti-tumor, hepatobiliary, and anti-infective therapeutic categories, alongside a health food product portfolio including probiotics, protein powders, and nutritional supplements. The company operates GMP-certified multi-dosage-form production lines and sells primarily through B2B distribution to medical institutions, with channel consultation and online product information support via caichon.com.

Product overview

Nanjing Caichang Trading Co.，Ltd (桐方药业（北京）有限公司) operates as a comprehensive pharmaceutical and health company with a dual-track product portfolio spanning clinical pharmaceuticals and health foods. The pharmaceutical portfolio centers on gynecological medications (甲硝唑阴道凝胶, 黄藤素阴道凝胶, 抗宫炎分散片), topical anesthetics (复方利多卡因乳膏), hepatobiliary and anti-inflammatory drugs (美洛昔康片, 垂盆草分散片, 头孢粉针剂), and anti-tumor medications (依西美坦片). The health food division includes protein supplements, probiotic beverages, botanical-based functional drinks, and comprehensive health gift boxes (东方心益礼盒). The company has established a full-industry chain layout integrating pharmaceutical R&D, production, and sales, serving both clinical medical institutions and consumer health markets.

Differentiator

Problem solved

Functional benefit

Brands

• 尼美欣: 甲硝唑阴道凝胶 product brand
• 东方心益

Products and services

• Gynecological Medications (妇科药品) Branded gynecological pharmaceutical products for women's health treatment, sold to hospitals, gynecology clinics, and women's health departments.
• Topical Anesthetic Preparations (外用局麻药) Specialty topical anesthetic products for surgical and outpatient procedures, distributed to medical institutions and surgical centers.
• Anti-tumor Drugs (抗肿瘤药) Pharmaceutical oncology products for tumor treatment, supplied to oncology treatment facilities and hospitals.
• Hepatobiliary Medications (肝胆药品) Pharmaceutical products for liver and gallbladder conditions, sold to medical institutions and pharmacies.
• Anti-infective Medications (抗感染药) Anti-infective pharmaceutical products supplied to medical institutions and recognized internationally through Bill & Melinda Gates Foundation collaborations.
• Health Food Products (保健食品) Consumer health food product line including probiotics, protein powders, and nutritional supplements, sold through consumer and retail channels.

Quantifiable outcome

• Metronidazole Vaginal Gel received Beijing New Technology Product (Service) Certification, expanding market differentiation advantage
• +2 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Five partnerships are on record, tiered core and flagship.

• 华控创新（北京）药物研究院有限公司 (Huakong Innovation (Beijing) Drug Research Institute Co., Ltd.)coreOthersWholly-owned subsidiary of Tongfang Pharmaceutical providing pharmaceutical R&D capabilities.
• 北京华控健康科技有限公司 (Beijing Huakong Health Technology Co., Ltd.)coreOthersWholly-owned subsidiary focused on health technology development.
• 重庆康乐制药有限公司 (Chongqing Kangle Pharmaceutical Co., Ltd.)coreOthersControlled subsidiary engaged in pharmaceutical manufacturing.
• 重庆华控康乐药物研究有限公司 (Chongqing Huakong Kangle Drug Research Co., Ltd.)coreOthersControlled subsidiary focused on drug research and development.
• 比尔及梅琳达·盖茨基金会 (Bill & Melinda Gates Foundation)flagshipStrategic or Co-development PartnerThe Gates Foundation selected Compound Lidocaine Cream as the designated mucosal anesthetic for their African male circumcision public health assistance project, demonstrating international recognition of the product's quality.

Scale indicators8 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Livzon Pharmaceutical Group: Diversified Chinese pharma manufacturer with significant gynecological, anti-infective, and oncology product lines and a health/nutritional supplement business — directly comparable in product matrix breadth and scale to Tongfang.
• Luye Pharma Group: China-based pharmaceutical group with a comparable diversified portfolio across oncology, women's health, and specialty dosage forms, overlapping with Tongfang's therapeutic and formulation profile and a similar mid-cap scale.
• China Grand Pharmaceutical and Healthcare Holdings: Mid-sized Hong Kong-listed Chinese pharma with a similarly diversified generic and specialty drug portfolio spanning multiple therapeutic areas including anti-infectives and women's health products, making it a close size and business-model match for Tongfang.
• Zhejiang Xianju Pharmaceutical: Chinese generic pharma manufacturer with a strong focus on women's health and gynecological products, overlapping directly with Tongfang's flagship gynecological franchise including vaginal gel formulations.

Broad incumbents

• Yangtze River Pharmaceutical Group: One of China's largest privately held pharma manufacturers with diverse drug categories and large-scale GMP manufacturing capacity; comparable in multi-dosage form capability and breadth, but at significantly greater scale.
• Shanghai Fosun Pharmaceutical: Diversified Chinese pharma group with broad manufacturing capabilities and a global footprint; comparable in multi-therapeutic portfolio and manufacturing scale, though considerably larger and more internationally diversified.
• Shanghai Pharmaceuticals Holding: Major Shanghai-listed Chinese pharma incumbent with diversified R&D, manufacturing, and distribution across most therapeutic categories; provides a reference point for what a fully scaled Tongfang could evolve into.
• Yunnan Baiyao Group: Established Chinese pharma with a long heritage, broad pharmaceutical and health product portfolio, and strong consumer health brand — comparable multi-decade industry tenure and dual pharma/consumer strategy.
• China Resources Double-Crane Pharmaceutical: Large SOE-backed Chinese pharma manufacturer with a broad multi-therapeutic portfolio and significant manufacturing scale; comparable SOE ownership structure and broader, more established product range.

Regional players

• Yiling Pharmaceutical: Mid-cap Chinese pharma with a portfolio spanning oncology, hepatobiliary, and anti-infective products including TCM-botanical medicines; overlapping therapeutic categories and Chinese-domestic market focus with Tongfang.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/%E5%8D%97%E4%BA%AC%E8%B4%A2%E6%98%8C%E5%95%86%E8%B4%B8%E6%9C%89%E9%99%90%E8%B4%A3%E4%BB%BB%E5%85%AC%E5%8F%B8

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nanjing Caichang Trading Co.，Ltd